Literature DB >> 8415688

Vitamin D-influenced gene expression via a ligand-independent, receptor-DNA complex intermediate.

T K Ross1, H M Darwish, V E Moss, H F DeLuca.   

Abstract

A lingering question regarding the regulation of target gene expression by 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] has been the delineation of vitamin D receptor (VDR)-DNA binding and transactivation. This report confirms that initial VDR-DNA interaction occurs in a ligand-independent fashion. An electrophoretic mobility-shift analysis demonstrated that VDR, derived from extracts of the small intestines of vitamin D-deficient rats, is capable of binding a vitamin D response element (DRE). Additional mobility-shift studies using either porcine-derived VDR or recombinant rat VDR from insect cells revealed DRE-binding capability in the absence of 1,25-(OH)2D3. The reactions were performed in various salt environments, with the maximum of porcine VDR-DRE and rat VDR-DRE binding detected at 100 mM and 150 mM KCl, respectively. The addition of 1,25-(OH)2D3 to an identical set of reaction mixtures resulted in increased DRE binding with greater affinities exhibited by both VDR types. These two phenomena were confirmed upon examination of an elution profile of VDR bound to DRE-linked Sepharose. When a linear KCl gradient was used for elution without the addition of 1,25-(OH)2D3, the peak of VDR was 205 mM KCl; the presence of exogenous hormone shifted the maximum VDR elution to a position corresponding to 265 mM KCl. Based on these data and previous reports on VDR-mediated transactivation, we propose a model for 1,25-(OH)2D3-influenced target gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415688      PMCID: PMC47546          DOI: 10.1073/pnas.90.20.9257

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions.

Authors:  E L Smith; N C Walworth; M F Holick
Journal:  J Invest Dermatol       Date:  1986-06       Impact factor: 8.551

2.  Affinity purification of sequence-specific DNA binding proteins.

Authors:  J T Kadonaga; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Biological activity of 25-hydroxyergocalciferol in rats.

Authors:  T Suda; H F DeLuca; Y Tanaka
Journal:  J Nutr       Date:  1970-09       Impact factor: 4.798

4.  DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3.

Authors:  M B Demay; J M Gerardi; H F DeLuca; H M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

5.  1 alpha,25-Dihydroxyvitamin D3 receptors in human thymic and tonsillar lymphocytes.

Authors:  D M Provvedini; C M Rulot; R E Sobol; C D Tsoukas; S C Manolagas
Journal:  J Bone Miner Res       Date:  1987-06       Impact factor: 6.741

6.  1,25-Dihydroxyvitamin D3 restores fertility of vitamin D-deficient female rats.

Authors:  G G Kwiecinksi; G I Petrie; H F DeLuca
Journal:  Am J Physiol       Date:  1989-04

7.  Vitamin D deficiency suppresses cell-mediated immunity in vivo.

Authors:  S Yang; C Smith; J M Prahl; X Luo; H F DeLuca
Journal:  Arch Biochem Biophys       Date:  1993-05-15       Impact factor: 4.013

8.  Characterization of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin.

Authors:  R U Simpson; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.

Authors:  J Hosomi; J Hosoi; E Abe; T Suda; T Kuroki
Journal:  Endocrinology       Date:  1983-12       Impact factor: 4.736

10.  Identification of the porcine intestinal 1,25-dihydroxyvitamin D3 receptor on sodium dodecyl sulfate/polyacrylamide gels by renaturation and immunoblotting.

Authors:  M C Dame; E A Pierce; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more
  6 in total

1.  Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.

Authors:  Hong Zhang; Zhe Shen; Yiming Lin; Jie Zhang; Yuwei Zhang; Peihao Liu; Hang Zeng; Mengli Yu; Xueyang Chen; Longgui Ning; Xinli Mao; Li Cen; Chaohui Yu; Chengfu Xu
Journal:  J Biol Chem       Date:  2020-02-12       Impact factor: 5.157

2.  An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3.

Authors:  Robert D Nerenz; Melissa L Martowicz; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2008-01-17

Review 3.  Vitamin D in cutaneous carcinogenesis: part I.

Authors:  Jean Y Tang; Teresa Fu; Christopher Lau; Dennis H Oh; Daniel D Bikle; Maryam M Asgari
Journal:  J Am Acad Dermatol       Date:  2012-11       Impact factor: 11.527

4.  Expression of the vitamin d receptor is increased in the hypertrophic heart.

Authors:  Songcang Chen; Denis J Glenn; Wei Ni; Christopher L Grigsby; Keith Olsen; Minobu Nishimoto; Christopher S Law; David G Gardner
Journal:  Hypertension       Date:  2008-10-20       Impact factor: 10.190

5.  Synthesis and Biological Activity of Diastereomeric and Geometric Analogs of Calcipotriol, PRI-2202 and PRI-2205, Against Human HL-60 Leukemia and MCF-7 Breast Cancer Cells.

Authors:  Magdalena Milczarek; Michał Chodyński; Beata Filip-Psurska; Agnieszka Martowicz; Małgorzata Krupa; Krzysztof Krajewski; Andrzej Kutner; Joanna Wietrzyk
Journal:  Cancers (Basel)       Date:  2013-10-31       Impact factor: 6.639

6.  Valproate and Short-Chain Fatty Acids Activate Transcription of the Human Vitamin D Receptor Gene through a Proximal GC-Rich DNA Region Containing Two Putative Sp1 Binding Sites.

Authors:  Marta Moreno-Torres; Carla Guzmán; Petar D Petrov; Ramiro Jover
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.